APOE and Alzheimer disease: For example, apolipoprotein E (APOE)-e4 allele status, by far the most relevant genetic risk factor for AD, has been linked with both responsiveness and nonresponsiveness to AChEIs in many studies although a meta-analysis [6] indicated that APOE4 does not significantly affect responses to AChEI treatment.